David Geffen School of Medicine at UCLA — Los Angeles, California

Public research footprint of David Geffen School of Medicine at UCLA, compiled from the ClinicalTrials.gov public registry.

160

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Diffuse Large B-cell Lymphoma (DLBCL) · Developmental and Epileptic Encephalopathy · Relapsed/Refractory Follicular Lymphoma · Cancer of the Liver

Recently updated registry entries

NCT06379789 — A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene… (Recruiting)
NCT06517693 — Safety and Pharmacokinetics Study of PGT121.414.LS Alone and in Combination With… (Recruiting)
NCT04663347 — Safety and Efficacy Trial of Epcoritamab Combinations in Subjects With B-cell Non-Hodgkin… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at David Geffen School of Medicine at UCLA?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.